The publisher, authors, editors, syndication partners, and all distribution platforms make no warranties or representations regarding the completeness, accuracy, or reliability of the information and expressly disclaim any and all liability for any losses, damages, or harm resulting from the use or misuse of any product referenced in this content
TB-500 has been studied for wound healing and skin repair, cardiac tissue recovery, corneal repair, hair follicle stimulation, and inflammatory modulation
However, its broader regulatory status is complex - FDA has raised regulatory and safety concerns regarding certain BPC-157-related bulk substances used in compounding contexts, and classifications may vary by use, jurisdiction, and product category
doi: 10.3389/fphar.2022.1026182 Received 23 August 2022 Accepted 23 November 2022 Published 14 December 2022 Volume 13 - 2022 Edited by Junmin Zhang, Lanzhou University, China Reviewed by Yurong Lai, Gilead, United States Mei-Hua Qu, Weifang Second Peoples Hospital, China Updates Copyright 2022 He, Feng, Guo, Zhou, Li, Zhang, Zhang, Wang, Wang, Hao, Zhang, Gao, Gu, Zhang, Li and Li
If you're a founder or product leader thinking seriously about the peptide space and want to think through what building this right actually looks like, we'd like to have that conversation.
